Tumor angiogenesis and molecular targets
Submission Deadline: 31 Dec 2009
Guest Editor
Keywords
- Cell Biology
- Cancer
- Technology
- Therapeutics
- Molecular Biology
Published Papers (7)
First-principles simulation of photoreactions in biological systems
Front. Biosci. (Landmark Ed) 2009, 14(13), 4862–4877; https://doi.org/10.2741/3574
(This article belongs to the Special Issue Tumor angiogenesis and molecular targets)
Transforming growth factor-beta signaling and tumor angiogenesis
Front. Biosci. (Landmark Ed) 2009, 14(13), 4848–4861; https://doi.org/10.2741/3573
(This article belongs to the Special Issue Tumor angiogenesis and molecular targets)
Tumor angiogenesis and molecular targets for therapy
Tumor angiogenesis and molecular targets for therapy
Front. Biosci. (Landmark Ed) 2009, 14(10), 3962–3973; https://doi.org/10.2741/3504
(This article belongs to the Special Issue Tumor angiogenesis and molecular targets)
Proteomics strategies for target identification and biomarker discovery in cancer
Front. Biosci. (Landmark Ed) 2009, 14(9), 3292–3303; https://doi.org/10.2741/3452
(This article belongs to the Special Issue Tumor angiogenesis and molecular targets)
Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications
Front. Biosci. (Landmark Ed) 2009, 14(8), 3094–3110; https://doi.org/10.2741/3438
(This article belongs to the Special Issue Tumor angiogenesis and molecular targets)
Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein
Front. Biosci. (Landmark Ed) 2009, 14(8), 2911–2922; https://doi.org/10.2741/3422
(This article belongs to the Special Issue Tumor angiogenesis and molecular targets)
Tyrosine kinase inhibitors of VEGF receptors: clinical issues and remaining questions
Front. Biosci. (Landmark Ed) 2009, 14(6), 2248–2268; https://doi.org/10.2741/3377
(This article belongs to the Special Issue Tumor angiogenesis and molecular targets)